SVB Wealth LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 19.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,062 shares of the company’s stock after selling 984 shares during the quarter. SVB Wealth LLC’s holdings in HCA Healthcare were worth $1,233,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. 1ST Source Bank increased its holdings in HCA Healthcare by 0.4% in the first quarter. 1ST Source Bank now owns 8,582 shares of the company’s stock valued at $2,263,000 after buying an additional 37 shares during the last quarter. Brown Brothers Harriman & Co. increased its holdings in HCA Healthcare by 9.7% in the first quarter. Brown Brothers Harriman & Co. now owns 420 shares of the company’s stock valued at $111,000 after buying an additional 37 shares during the last quarter. Profit Investment Management LLC increased its holdings in HCA Healthcare by 2.1% in the second quarter. Profit Investment Management LLC now owns 1,800 shares of the company’s stock valued at $546,000 after buying an additional 37 shares during the last quarter. HHM Wealth Advisors LLC grew its holdings in shares of HCA Healthcare by 0.7% during the first quarter. HHM Wealth Advisors LLC now owns 5,493 shares of the company’s stock valued at $1,448,000 after purchasing an additional 39 shares during the last quarter. Finally, Westshore Wealth LLC grew its holdings in shares of HCA Healthcare by 2.2% during the first quarter. Westshore Wealth LLC now owns 1,866 shares of the company’s stock valued at $492,000 after purchasing an additional 40 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Trading Down 0.0 %
NYSE HCA opened at $245.38 on Friday. HCA Healthcare, Inc. has a 1-year low of $178.32 and a 1-year high of $304.86. The company has a current ratio of 1.20, a quick ratio of 1.03 and a debt-to-equity ratio of 79.26. The company has a market capitalization of $66.74 billion, a PE ratio of 12.07, a price-to-earnings-growth ratio of 1.26 and a beta of 1.62. The firm’s fifty day simple moving average is $264.85 and its 200-day simple moving average is $273.82.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Thursday, July 27th. The company reported $4.29 earnings per share for the quarter, topping analysts’ consensus estimates of $4.28 by $0.01. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. The business had revenue of $15.86 billion for the quarter, compared to the consensus estimate of $15.63 billion. During the same period in the prior year, the business posted $4.21 earnings per share. HCA Healthcare’s revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 18.48 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 29th. Investors of record on Friday, September 15th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend was Thursday, September 14th. HCA Healthcare’s dividend payout ratio is presently 11.81%.
Insider Buying and Selling
In related news, SVP Jeffrey E. Cohen sold 1,500 shares of the company’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $270.00, for a total value of $405,000.00. Following the completion of the sale, the senior vice president now directly owns 4,414 shares in the company, valued at $1,191,780. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, SVP Jeffrey E. Cohen sold 1,500 shares of the company’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $270.00, for a total transaction of $405,000.00. Following the completion of the sale, the senior vice president now directly owns 4,414 shares in the company, valued at $1,191,780. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 5,204 shares of the company’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $269.12, for a total transaction of $1,400,500.48. Following the sale, the senior vice president now owns 19,760 shares of the company’s stock, valued at $5,317,811.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 9,620 shares of company stock worth $2,592,820. Corporate insiders own 1.60% of the company’s stock.
Analyst Ratings Changes
Several research firms have recently commented on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $315.00 target price on shares of HCA Healthcare in a report on Thursday, September 14th. Truist Financial upped their target price on HCA Healthcare from $325.00 to $340.00 in a report on Tuesday, June 20th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Mizuho upped their price target on HCA Healthcare from $305.00 to $325.00 in a report on Tuesday, July 11th. Finally, 1-800-FLOWERS.COM reaffirmed a “maintains” rating on shares of HCA Healthcare in a report on Wednesday, June 28th. Two equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $310.86.
Check Out Our Latest Stock Analysis on HCA
HCA Healthcare Company Profile
(Free Report)HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HCA Healthcare wasn’t on the list.
While HCA Healthcare currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report[ad_2]
Source link